1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 12(12):e154-235.
2. Gibbon JH, Jr: Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954; (3):171-185; passim.
3. DeBakey ME: Development of mechanical heart devices. Ann Thorac Surg 2005; 79(6):S2228-2231.
4. Gemmato CJ, Forrester MD, Myers TJ, Frazier OH, Cooley DA: Thirty-five years of mechanical circulatory support at the Texas Heart Institute: an updated overview. Tex Heart Inst J 2005; (2):168-177.
5. DeVries WC, Anderson JL, Joyce LD, Anderson FL, Hammond EH, et al: Clinical use of the total artificial heart.
NEJM 1984; 310(5):273-278.
[PubMed: 6690950]
6. Sun BC, Catanese KA, Spanier TB, Flannery MR, Gardocki MT, et al: 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience.
Ann Thorac Surg 1999; 68(2):688-694.
[PubMed: 10475472]
7. Rose EA, Gelijns
AC, Moskowitz AJ, Heitjan DF, Stevenson LW, et al: Long-term mechanical left ventricular assistance for end-stage heart failure.
NEJM 2001; 345(20):1435-1443.
[PubMed: 11794191]
8. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, et al: Advanced heart failure treated with continuous-flow left ventricular assist device.
NEJM 2009; 361(23):2241-2251.
[PubMed: 19920051]
9. Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, et al: Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
Eur Heart J 2009; 30(17):2102-2108.
[PubMed: 19617601]
10. Koerner MM, Jahanyar J: Assist devices for circulatory support in therapy-refractory acute heart failure.
Curr Opin Cardiol 2008; 23(4):399-406.
[PubMed: 18520726]
11. Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, et al: A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
J Am Coll Cardiol 2008; 52(19): 1584-1588.
[PubMed: 19007597]
12. Goldstein DJ: Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation 2003; 108(Suppl 1):II272-277.
13. Westaby S, Siegenthaler M, Beyersdorf F, Massetti M, Pepper J, et al: Destination therapy with a rotary blood pump and novel power delivery.
Eur J Cardiothorac Surg 2010; 37(2):350-356.
[PubMed: 19589689]
14. Liden H, Haraldsson A, Ricksten SE, Kjellman U, Wiklund L: Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
Eur J Cardiothorac Surg 2009; 35(6):1029-1034; discussion 34-35.
[PubMed: 19211259]
15. Salzberg SP, Lachat ML, von Harbou K, Zund G, Turina MI: Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates.
Eur J Cardiothorac Surg 2005; 27(2):222-225.
[PubMed: 15691674]
16. Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, et al: Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
J Thorac Cardiovasc Surg 2007; 133(3):689-695.
[PubMed: 17320566]
17. Zimpfer D, Zrunek P, Sandner S, Schima H, Grimm M, et al: Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices.
Eur J Cardiothorac Surg 2007; 31(4):698-702.
[PubMed: 17289396]
18. Gronda E, Bourge RC, Costanzo MR, Deng M, Mancini D, et al: Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates–2006.
J Heart Lung Transplant 2006; 25(9):1043-1056.
[PubMed: 16962465]
19. Etz CD, Welp HA, Tjan TD, Hoffmeier A, Weigang E, et al: Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices.
Ann Thorac Surg 2007; 83(5):1697-1705.
[PubMed: 17462383]
21. Lietz K, Miller LW: Patient selection for left-ventricular assist devices.
Curr OpinCardiol 2009; 24(3):246-251.
[PubMed: 19318935]
22. Lietz K, Long JW, Kfoury AG, Slaughter MS,
Silver MA, et al: Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Circulation 2007; 116(5):497-505.
[PubMed: 17638928]
23. Klotz S, Jan Danser AH, Burkhoff D: Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. Prog Biophys Mol Biol 2008; 97(2-3):479-496.
24. Holman WL, Kormos RL, Naftel DC, Miller MA, Pagani FD, et al: Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study.
J Heart Lung Transplant 2009; 28(1):44-50.
[PubMed: 19134530]
25. Aaronson KD, Patel H, Pagani FD: Patient selection for left ventricular assist device therapy. Ann Thorac Surg 2003; 75(6 Suppl):S29-35.
26. Miller LW: Patient selection for the use of ventricular assist devices as a bridge to transplantation. Ann Thorac Surg 2003; 75(6 Suppl):S66-71.
27. Norman JC, Cooley DA, Igo SR, Hibbs CW, Johnson MD, et al: Prognostic indices for survival during postcardiotomy intra-aortic balloon pumping. Methods of scoring and classification, with implications for left ventricular assist device utilization.
J Thorac Cardiovasc Surg 1977; 74(5): 709-720.
[PubMed: 335170]
28. Stevenson LW: Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy.
Circulation 2003; 108(4):492-497.
[PubMed: 12885733]
29. Stevenson LW: Clinical use of inotropic therapy for heart failure: looking backward or forward? Part I: inotropic infusions during hospitalization. Circulation 2003; 22;108(3):367-372.
30. Kirklin JK, Naftel DC, Stevenson LW, Kormos RL, Pagani FD, et al: INTERMACS database for durable devices for circulatory support: first annual report.
J Heart Lung Transplant 2008; 27(10):1065-1072.
[PubMed: 18926395]
31. Stevenson LW, Couper G: On the fledgling field of mechanical circulatory support.
J Am Coll Cardiol 2007; 50(8):748-751.
[PubMed: 17707179]
32. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, et al: INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009; Jun;28(6):535-541.
33. Oz MC, Goldstein DJ, Pepino P, Weinberg AD, Thompson SM, et al: Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation 1995; 92(9 Suppl):II169-73.
34. Farrar DJ, Hill JD: Recovery of major organ function in patients awaiting heart transplantation with Thoratec ventricular assist devices. Thoratec Ventricular Assist Device Principal Investigators.
J Heart Lung Transplant 1994; 13(6):1125-1132.
[PubMed: 7865520]
35. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, et al: Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation.
J Thorac Cardiovasc Surg 2001; 122(6):1186-1195.
[PubMed: 11726895]
36. Jett GK: ABIOMED BVS 5000: experience and potential advantages.
Ann Thorac Surg 1996; 61(1):301-304; discussion 11-13.
[PubMed: 8561594]
37. Letsou GV, Myers TJ, Gregoric ID, Delgado R, Shah N, et al. Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months.
Ann Thorac Surg 2003; 76(4): 1167-1170.
[PubMed: 14530006]
38. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, et al: End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
J Heart Lung Transplant 2007; 26(8):815-818.
[PubMed: 17692785]
39. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, et al: Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
J Am Coll Cardiol 2009; 54(4):312-321.
[PubMed: 19608028]
40. Sandner SE, Zimpfer D, Zrunek P, Dunkler D, Schima H, et al. Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices.
J Heart Lung Transplant 2008; 27(5):469-473.
[PubMed: 18442710]
41. Butler J, Geisberg C, Howser R, Portner PM, Rogers JG, et al: Relationship between renal function and left ventricular assist device use.
Ann Thorac Surg 2006; 81(5):1745-1751.
[PubMed: 16631666]
42. Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, et al: Renal function and outcome after continuous flow left ventricular assist device implantation.
Ann Thorac Surg 2009; 87(4):1072-1078.
[PubMed: 19324130]
43. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, et al: Revised screening scale to predict survival after insertion of a left ventricular assist device.
J Thorac Cardiovasc Surg 2003; 125(4):855-862.
[PubMed: 12698149]
44. Reinhartz O, Farrar DJ, Hershon JH, Avery GJ, Jr, Haeusslein EA, et al: Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation.
J Thorac Cardiovasc Surg 1998; 116(4):633-640.
[PubMed: 9766593]
45. Gracin N, Johnson MR, Spokas D, Allen J, Bartlett L, et al: The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation.
J Heart Lung Transplant 1998; 17(10):1017-1023.
[PubMed: 9811411]
46. Levy WC, Mozaffarian D, Linker DT, Farrar DJ, Miller LW: Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?
J Heart Lung Transplant 2009; 28(3):231-236.
[PubMed: 19285613]
47. Schaffer JM, Allen JG, Weiss ES, Patel ND, Russell SD, et al: Evaluation of risk indices in continuous-flow left ventricular assist device patients.
Ann Thorac Surg 2009; 88(6):1889-1896.
[PubMed: 19932256]
48. Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, et al: Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
J Heart Lung Transplant 2006; 25(1):1-6.
[PubMed: 16399523]
49. Patel ND, Weiss ES, Schaffer J, Ullrich SL, Rivard DC, et al: Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
Ann Thorac Surg 2008; 86(3):832-840; discussion 832-840.
[PubMed: 18721570]
50. Van Meter CH, Jr: Right heart failure: best treated by avoidance. Ann Thorac Surg 2001; 71(3 Suppl):S220-222.
51. Matthews JC, Koelling TM, Pagani FD, Aaronson KD: The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates.
J Am Coll Cardiol 2008; 51(22):2163-2172.
[PubMed: 18510965]
52. Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, Navia JL, et al: Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 2002; 106(12 Suppl 1):I198-202.
53. Fitzpatrick JR, 3rd, Frederick JR, Hsu VM, Kozin ED, O'Hara ML, et al: Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support.
J Heart Lung Transplant 2008; 27(12):1286-1292.
[PubMed: 19059108]
54. Moazami N, Pasque MK, Moon MR, Herren RL, Bailey MS, et al: Mechanical support for isolated right ventricular failure in patients after cardiotomy.
J Heart Lung Transplant 2004; 23(12):1371-1375.
[PubMed: 15607666]
55. Kapur NK, Conte JV, Resar JR: Percutaneous closure of patent foramen ovale for refractory hypoxemia after HeartMate II left ventricular assist device placement. J Invasive Cardiol 2007; 19(9):E268-270.
56. Cregler LL: Antithrombotic therapy in left ventricular thrombosis and systemic embolism. Am Heart J 1992; 123(4 Pt 2):1110-1114.
57. McCarthy PM, Wang N, Vargo R: Preperitoneal insertion of the HeartMate 1000 IP implantable left ventricular assist device.
Ann Thorac Surg 1994; 57(3):634-637; discussion 7-8.
[PubMed: 8147633]
58. Kavarana MN, Pessin-Minsley MS, Urtecho J, Catanese KA, Flannery M, et al: Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem.
Ann Thorac Surg 2002; 73(3): 745-750.
[PubMed: 11899176]
59. Argenziano M, Choudhri AF, Oz MC, Rose EA, Smith CR, et al: A prospective randomized trial of
arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement.
Circulation 1997; 96(9 Suppl):II-286-290.
60. Morrone TM, Buck LA, Catanese KA, Goldsmith RL, Cahalin LP, et al: Early progressive mobilization of patients with left ventricular assist devices is safe and optimizes recovery before heart transplantation.
J Heart Lung Transplant 1996; 15(4):423-429.
[PubMed: 8732603]
61. Genovese EA, Dew MA, Teuteberg JJ, Simon MA, Kay J, et al: Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation.
Ann Thorac Surg 2009; 88(4):1162-1170.
[PubMed: 19766801]
62. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, et al: Use of a continuous-flow device in patients awaiting heart transplantation.
NEJM 2007; 357(9): 885-896.
[PubMed: 17761592]
63. Struber M, Sander K, Lahpor J, Ahn H, Litzler PY, et al: HeartMate II left ventricular assist device: early European experience.
Eur J Cardiothorac Surg 2008; 34(2):289-294.
[PubMed: 18571932]
64. Haj-Yahia S, Birks EJ, Rogers P, Bowles C, Hipkins M, et al: Midterm experience with the Jarvik 2000 axial flow left ventricular assist device.
J Thorac Cardiovasc Surg 2007; 134(1):199-203.
[PubMed: 17599509]
65. Morgan JA, John R, Rao V, Weinberg AD, Lee BJ, et al: Bridging to transplant with the HeartMate left ventricular assist device: the Columbia Presbyterian 12-year experience.
J Thorac Cardiovasc Surg 2004; 127(5): 1309-1316.
[PubMed: 15115987]
66. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, et al: Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008; (4):1227-1234; discussion 34-35.
67. Russo MJ, Hong KN, Davies RR, Chen JM, Sorabella RA, et al: Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices.
J Thorac Cardiovasc Surg 2009; 138(6):1425-1432 e1-3.
[PubMed: 19931672]
68. Cleveland JC, Jr, Grover FL, Fullerton DA, Campbell DN, Mitchell MB, et al: Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
J Thorac Cardiovasc Surg 2008; 136(3):774-777.
[PubMed: 18805284]
69. Taylor DO, Stehlik J, Edwards LB, Aurora P, Christie JD, et al: Registry of the international society for heart and lung transplantation: twenty-sixth official adult heart transplant report-2009.
J Heart Lung Transplant 2009; 28(10):1007-1022.
[PubMed: 19782283]
70. Farrar DJ, Hill JD, Pennington DG, McBride LR, Holman WL, et al:. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the Thoratec ventricular assist device as a bridge to cardiac transplantation.
J Thorac Cardiovasc Surg 1997; 113(1): 202-209.
[PubMed: 9011691]
71. Santambrogio L, Bianchi T, Fuardo M, Gazzoli F, Veronesi R, et al: Right ventricular failure after left ventricular assist device insertion: preoperative risk factors. Interact Cardiovasc Thorac Surg 2006; (4):379-382.
72. Kormos RL, Gasior TA, Kawai A, Pham SM, Murali S, et al: Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support.
J Thorac Cardiovasc Surg 1996; 111(4):773-782; discussion 82-83.
[PubMed: 8614137]
73. Fitzpatrick JR, 3rd, Frederick JR, Hiesinger W, Hsu VM, McCormick RC, et al: Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device.
J Thorac Cardiovasc Surg 2009; 137(4):971-977.
[PubMed: 19327526]
74. Mancini DM, Beniaminovitz A, Levin H, Catanese K, Flannery M, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure.
Circulation 1998; 98(22):2383-2389.
[PubMed: 9832482]
75. Hetzer R, Muller JH, Weng Y, Meyer R, Dandel M: Bridging-to-recovery. Ann Thorac Surg 2001; 71(3 Suppl):S109-113; discussion S14-15.
76. Dandel M, Weng Y, Siniawski H, Potapov E, Lehmkuhl HB, et al: Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 2005; 112(9 Suppl):I37-45.
77. Simon D, Fischer S, Grossman A, Downer C, Hota B, et al: Left ventricular assist device-related infection: treatment and outcome.
Clin Infect Dis 2005; 40(8):1108-1115.
[PubMed: 15791509]
78. Maybaum S, Mancini D, Xydas S, Starling RC, Aaronson K, et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
Circulation 2007; 115(19):2497-2505.
[PubMed: 17485581]
79. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. NEJM 2006; (18):1873-1884.
80. Alba
AC, Rao V, Ivanov J, Ross HJ, Delgado DH: Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation.
J Heart Lung Transplant 2009; 28(8):827-833.
[PubMed: 19632580]
81. Hill JD, Farrar DJ, Naka Y, Chen JM, Portner PM, et al. (eds): Positive Displacement Ventricular Assist Devices. St Louis, Elsevier, 2006.
82. Goldstein DJ, Beauford RB: Left ventricular assist devices and bleeding: adding insult to injury. Ann Thorac Surg 2003; 75(6 Suppl):S42-47.
83. Crow S, John R, Boyle A, Shumway S, Liao K, et al: Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.
J Thorac Cardiovasc Surg 2009; 137(1):208-215.
[PubMed: 19154927]
84. Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB: Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).
J Am Coll Cardiol 2009; 53(23):2162-2167.
[PubMed: 19497443]
85. Tsukui H, Abla A, Teuteberg JJ, McNamara DM, Mathier MA, et al: Cerebrovascular accidents in patients with a ventricular assist device.
J Thorac Cardiovasc Surg 2007; 134(1):114-123.
[PubMed: 17599496]
86. Holman WL, Pae WE, Teutenberg JJ, Acker MA, Naftel DC, et al: INTERMACS: interval analysis of registry data.
J Am Coll Surg 2009; 208(5): 755-761; discussion 61-62.
[PubMed: 19476831]
87. Wood C, Maiorana A, Larbalestier R, Lovett M, Green G, et al: First successful bridge to myocardial recovery with a HeartWare HVAD.
J Heart Lung Transplant 2008; 27(6):695-697.
[PubMed: 18503974]